Additional file 1: of Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Table S1 Clinical characteristics of the melanoma cohort. Table S2 Survival analyses for studied biomarkers. Table S3 Comprehensive gene expression and mutational profile of melanoma cohort. Table S4 Over representation test results of categorical variables for gene expression clusters. Table S5 Over representation test results of gene ranks for gene expression clusters. Table S6 ORR for all biomarker groups studied. Table S7 Objective response rates for studied biomarkers. Table S8 Objective response counts for melanoma cohort. Table S9 ORR for training set response score groups. (XLSX 1378 kb)

表S1 黑色素瘤队列的临床特征。表S2 本次研究涉及生物标志物的生存分析。表S3 黑色素瘤队列的全面基因表达与突变谱。表S4 基因表达聚类的类别变量超富集检验（Over Representation Test）结果。表S5 基因表达聚类的基因秩次超富集检验结果。表S6 本次研究全部生物标志物组的客观缓解率（ORR，Objective Response Rate）。表S7 本次研究生物标志物的客观缓解率。表S8 黑色素瘤队列的客观缓解例数。表S9 训练集应答评分组的客观缓解率。（XLSX格式，文件大小1378千字节）